Full Press Release Details
• Australia-New Zealand
• Brazil
• Canada (EN)
• Canada (FR)
• China
• Colombia
• France
• Germany
• India
• Italy
• Japan
• Korea
• Mexico
• Middle East
• Philippines
• Poland
• Russia
• Singapore
• Spain
• Turkey
• United Kingdom
• United States
• Global English
• Global German
• Global Spanish
• Global France
• Latam
With the introduction of Imaging 360 AI assistant and embedded AI-assisted protocoling, Imaging 360 brings intelligence directly into the workflow, helping radiology teams access insights more effortlessly and make more consistent, informed protocoling Chicago — November 20, 2026 — GE HealthCare (Nasdaq: GEHC) today announced two new capabilities for Imaging 360, AI assistant and AI-assisted protocoling. The Imaging 360 AI assistant and AI-assist protocoling are designed to help imaging teams quickly find answers to protocol-related questions and support protocoling for CT and MR exams. Radiology departments manage complex workflows across sites, systems and care teams. Finding protocol information and analyzing the data can be time consuming. Selecting the appropriate protocol for each imaging order can also require significant time and attention from radiologists and technologists. In an analysis of two observational studies, researchers estimated that radiologists spend an average of 1.3 hours per day of their time on protocoling.[1] The new Imaging 360 features are designed to make these tasks efficient, giving teams access to the information and support they need in one place. “Radiology teams need tools that make everyday work more manageable, so they can focus their expertise where it matters most,” said Ryan Dobbe, General Manager of Advanced Imaging Solutions Digital Ecosystem at GE HealthCare. “These new Imaging 360 features are designed to give teams a clearer view of protocols across their enterprise and support more consistent protocoling decisions, while keeping operations more efficient.” Reducing the burden of data analysis The Imaging 360 AI assistant helps imaging leaders, administrators and protocol managers explore protocol related analytics by asking questions in natural English language. Embedded within Imaging 360, the assistant is designed to help users find answers without navigating multiple dashboards or manually reviewing data. It is for operational use and does not provide clinical interpretation or patient-specific recommendations. It is read-only and does not modify protocols or source data. Supporting more consistent protocoling across the enterprise AI assisted protocoling, part of Imaging 360, is a vendor-agnostic, multi-modality application designed to provide consistency in protocoling. Radiologists and technologists can review the recommendations to support their decision-making process before they select the protocol in the RIS. Together, the new features give imaging teams ways to understand protocol use across their organizations and support the decisions involved in preparing for individual exams. The Imaging 360 AI assistant and Imaging 360 AI-assisted protocoling will be demonstrated at the Radiological Society of North America (RSNA) 2026 Annual Meeting in GE HealthCare’s booth #7330.
• With the introduction of Imaging 360 AI assistant and embedded AI-assisted protocoling, Imaging 360 brings intelligence directly into the workflow, helping radiology teams access insights more effortlessly and make more consistent, informed protocoling
Chicago — November 20, 2026 — GE HealthCare (Nasdaq: GEHC) today announced two new capabilities for Imaging 360, AI assistant and AI-assisted protocoling. The Imaging 360 AI assistant and AI-assist protocoling are designed to help imaging teams quickly find answers to protocol-related questions and support protocoling for CT and MR exams.
Radiology departments manage complex workflows across sites, systems and care teams. Finding protocol information and analyzing the data can be time consuming. Selecting the appropriate protocol for each imaging order can also require significant time and attention from radiologists and technologists. In an analysis of two observational studies, researchers estimated that radiologists spend an average of 1.3 hours per day of their time on protocoling.[1] The new Imaging 360 features are designed to make these tasks efficient, giving teams access to the information and support they need in one place.
“Radiology teams need tools that make everyday work more manageable, so they can focus their expertise where it matters most,” said Ryan Dobbe, General Manager of Advanced Imaging Solutions Digital Ecosystem at GE HealthCare. “These new Imaging 360 features are designed to give teams a clearer view of protocols across their enterprise and support more consistent protocoling decisions, while keeping operations more efficient.”
Reducing the burden of data analysis
The Imaging 360 AI assistant helps imaging leaders, administrators and protocol managers explore protocol related analytics by asking questions in natural English language.
Embedded within Imaging 360, the assistant is designed to help users find answers without navigating multiple dashboards or manually reviewing data. It is for operational use and does not provide clinical interpretation or patient-specific recommendations. It is read-only and does not modify protocols or source data.
Supporting more consistent protocoling across the enterprise
AI assisted protocoling, part of Imaging 360, is a vendor-agnostic, multi-modality application designed to provide consistency in protocoling. Radiologists and technologists can review the recommendations to support their decision-making process before they select the protocol in the RIS.
Together, the new features give imaging teams ways to understand protocol use across their organizations and support the decisions involved in preparing for individual exams.
The Imaging 360 AI assistant and Imaging 360 AI-assisted protocoling will be demonstrated at the Radiological Society of North America (RSNA) 2026 Annual Meeting in GE HealthCare’s booth #7330.
[1] Source of Protocoling statistics: GE sponsored survey of 150 CT radiologists and technologists, January 2019
About GE HealthCare Technologies Inc. GE HealthCare is a leading global healthcare solutions provider of advanced medical technology, pharmaceutical diagnostics, and AI, cloud and software solutions that help clinicians tackle the world’s most complex diseases. Serving patients and providers for 130 years, GE HealthCare is delivering bold innovations designed for the next era of medicine across its Advanced Imaging Solutions, Pharmaceutical Diagnostics, and Patient Care Solutions segments to help clinicians deliver more personalized, precise patient care. We are a $20.6 billion business with approximately 54,000 colleagues working to create a world where healthcare has no limits. GE HealthCare is proud to be among 2026 Fortune World’s Most Admired Companies™. Follow us on LinkedIn, Facebook, Instagram, or visit our website for our latest news and perspectives.
About GE HealthCare Technologies Inc.
GE HealthCare is a leading global healthcare solutions provider of advanced medical technology, pharmaceutical diagnostics, and AI, cloud and software solutions that help clinicians tackle the world’s most complex diseases. Serving patients and providers for 130 years, GE HealthCare is delivering bold innovations designed for the next era of medicine across its Advanced Imaging Solutions, Pharmaceutical Diagnostics, and Patient Care Solutions segments to help clinicians deliver more personalized, precise patient care. We are a $20.6 billion business with approximately 54,000 colleagues working to create a world where healthcare has no limits.
GE HealthCare is proud to be among 2026 Fortune World’s Most Admired Companies™.
Follow us on LinkedIn, Facebook, Instagram, or visit our website for our latest news and perspectives.
Latest Press Release
GE HealthCare introduces new Imaging 360 features to simplify protocol management and support radiology workflows
GE HealthCare’s Phase 2 results support advancement of investigational manganese-based MRI contrast agent mangaciclanol into Phase 3 of LUMINA clinical trial